|
🐜
|
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
27 auth.
G. Kristjansdottir,
J. Sandling,
A. Bonetti,
I. Roos,
L. Milani,
Chuan Wang,
S. Gústafsdóttir,
S. Sigurdsson,
Anders Lundmark,
P. Tienari,
K. Koivisto,
I. Elovaara,
T. Pirttilä,
M. Reunanen,
L. Peltonen,
...
J. Saarela,
J. Hillert,
T. Olsson,
U. Landegren,
A. Alcina,
Ó. Fernández,
L. Leyva,
M. Guerrero,
M. Lucas,
Guillermo Izquierdo,
F. Matesanz,
A. Syvänen
|
7 |
2008 |
7
🐜
|
|
🐢
|
Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations
13 auth.
A. Alcina,
María M. Abad-Grau,
M. Fedetz,
G. Izquierdo,
M. Lucas,
Ó. Fernández,
D. Ndagire,
Antonio Catalá-Rabasa,
A. Ruíz,
J. Gayán,
...
C. Delgado,
C. Arnal,
F. Matesanz
|
7 |
2012 |
7
🐢
|
|
🐜
|
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
30 auth.
S. Malhotra,
C. Costa,
H. Eixarch,
C. Keller,
Lukas Amman,
H. Martínez-Banaclocha,
L. Midaglia,
E. Sarró,
I. Machín-Díaz,
L. Villar,
J. Triviño,
B. Oliver-Martos,
Laura Navarro Parladé,
Laura Calvo-Barreiro,
F. Matesanz,
...
K. Vandenbroeck,
E. Urcelay,
M. Martínez-Ginés,
Amalia Tejeda-Velarde,
N. Fissolo,
J. Castilló,
Alex Sánchez,
A. Robertson,
D. Clemente,
M. Prinz,
P. Pelegrín,
J. Lünemann,
C. Espejo,
X. Montalban,
M. Comabella
|
6 |
2020 |
6
🐜
|
|
🐢
|
IL2RA/CD25 Gene Polymorphisms: Uneven Association with Multiple Sclerosis (MS) and Type 1 Diabetes (T1D)
12 auth.
A. Alcina,
M. Fedetz,
D. Ndagire,
Ó. Fernández,
L. Leyva,
M. Guerrero,
...
María M. Abad-Grau,
C. Arnal,
C. Delgado,
M. Lucas,
G. Izquierdo,
F. Matesanz
|
6 |
2009 |
6
🐢
|
|
🐢
|
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
24 auth.
A. Alcina,
K. Vandenbroeck,
K. Vandenbroeck,
D. Otaegui,
A. Saiz,
J. R. González,
Ó. Fernández,
María L. Cavanillas,
M. Cénit,
R. Arroyo,
...
I. Alloza,
M. García-Barcina,
A. Antigüedad,
L. Leyva,
Guillermo Izquierdo,
M. Lucas,
M. Fedetz,
M. Pinto-Medel,
J. Olascoaga,
Y. Blanco,
M. Comabella,
X. Montalban,
E. Urcelay,
F. Matesanz
|
6 |
2010 |
6
🐢
|
|
🦁
|
Effects of the multiple sclerosis associated −330 promoter polymorphism in IL2 allelic expression
F. Matesanz,
M. Fedetz,
L. Leyva,
C. Delgado,
Ó. Fernández,
A. Alcina
|
6 |
2004 |
6
🦁
|
|
🐢
|
IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response
13 auth.
L. Leyva,
Ó. Fernández,
M. Fedetz,
Eva Blanco,
V. Fernández,
B. Oliver,
A. León,
M. Pinto-Medel,
C. Mayorga,
M. Guerrero,
...
G. Luque,
A. Alcina,
F. Matesanz
|
6 |
2005 |
6
🐢
|
|
🐜
|
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
58 auth.
C. Lill,
B. Schjeide,
C. Graetz,
M. Ban,
A. Alcina,
M. A. Ortiz,
Jennifer Pérez,
V. Damotte,
D. Booth,
Aitzkoa Lopez de Lapuente,
L. Broer,
M. Schilling,
D. Akkad,
O. Aktas,
I. Alloza,
...
A. Antigüedad,
R. Arroyo,
P. Blaschke,
M. Buttmann,
A. Chan,
Alastair Compston,
I. Cournu-Rebeix,
T. Dörner,
J. Epplen,
Ó. Fernández,
L. Gerdes,
L. Guillot-nöel,
H. Hartung,
S. Hoffjan,
G. Izquierdo,
A. Kemppinen,
A. Kroner,
C. Kubisch,
T. Kümpfel,
Shu-Chen Li,
U. Lindenberger,
P. Lohse,
C. Lubetzki,
F. Luessi,
S. Malhotra,
J. Mescheriakova,
X. Montalban,
C. Papeix,
L. F. Paredes,
P. Rieckmann,
E. Steinhagen-Thiessen,
A. Winkelmann,
U. Zettl,
R. Hintzen,
K. Vandenbroeck,
G. Stewart,
B. Fontaine,
M. Comabella,
E. Urcelay,
F. Matesanz,
S. Sawcer,
L. Bertram,
F. Zipp
|
6 |
2013 |
6
🐜
|
|
🐜
|
CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility
17 auth.
F. Blanco-Kelly,
F. Matesanz,
A. Alcina,
M. Teruel,
L. Diaz-Gallo,
M. Gómez‐García,
M. López-Nevot,
L. Rodrigo,
A. Nieto,
C. Cardeña,
...
G. Alcaín,
M. Díaz‐Rubio,
E. G. de la Concha,
Ó. Fernández,
R. Arroyo,
Javier Martín,
E. Urcelay
|
6 |
2010 |
6
🐜
|
